Tag Archives: Dr. Oystein Fluge and Professor Olav Mella

The Norwegian Rituxan study finally got published. Unfortunately, I don’t have a comment left in me today, but here is the abstract: Øystein Fluge1*, Ove Bruland1,2, Kristin Risa1, Anette Storstein3, Einar K. Kristoffersen4, Dipak Sapkota1, Halvor Næss3, Olav Dahl1,5, Harald Nyland3, Olav Mella1,5 1 Department of Oncology and Medical Physics, … Continue reading →